All Stories

  1. Capsule and PspA Cooperatively Confer Resistance of Streptococcus pneumoniae to the Human Defensin HNP-1
  2. Structural profiling of the pneumolysin epitope landscape uncovers a cross-species neutralising site across cholesterol-dependent cytolysins
  3. Capsule Regulation Shapes Klebsiella pneumoniae Pathogenesis by Balancing Adhesion, Biofilm Formation, and Intracellular Survival
  4. Identification of a novel gene associated with group B Streptococcus persister cell formation and biofilm production
  5. Overcoming Immune Evasion in Staphylococcus aureus: Strategies for Rational Vaccine Design
  6. Protection Against Pneumonia Induced by Vaccination with Fimbriae Subunits from Klebsiella pneumoniae
  7. Corynebacteria from the respiratory microbiota modulate inflammatory responses and associate with a reduced pneumococcal burden in the lungs
  8. Pneumococcal surface protein A (PspA) prevents killing of Streptococcus pneumoniae by indolicidin
  9. Role of the polyamine transporter PotABCD during biofilm formation by Streptococcus pneumoniae
  10. Biofilm-dispersed pneumococci induce elevated leukocyte and platelet activation
  11. HAMLET, a human milk protein-lipid complex, modulates amoxicillin induced changes in an ex vivo biofilm model of the oral microbiome
  12. Cannabis use, mental health, and problematic Internet use in Quebec: A study protocol
  13. HAMLET, a human milk protein-lipid complex, modulates amoxicillin-induced changes in anex vivobiofilm model of the oral microbiome
  14. Role of serotype and virulence determinants of Streptococcus pyogenes biofilm bacteria in internalization and persistence in epithelial cells in vitro
  15. Treatment of Mouse Infants with Amoxicillin, but Not the Human Milk-Derived Antimicrobial HAMLET, Impairs Lung Th17 Responses
  16. Measuring Niche-Associated Metabolic Activity in Planktonic and Biofilm Bacteria
  17. Editorial: Microbial biofilms interacting with host mucosal surfaces
  18. A Mouse Model for the Transition of <em>Streptococcus pneumoniae</em> from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
  19. A particulate matter: How environmental irritants and particulate matter increase sensitivity to bacterial respiratory tract infections. Commentary for “Underground railway particulate matter and susceptibility to pneumococcal infection”
  20. Influence of the Polysaccharide Capsule on the Bactericidal Activity of Indolicidin on Streptococcus pneumoniae
  21. Klebsiella pneumoniae Biofilms and Their Role in Disease Pathogenesis
  22. Functional Antibodies Against SARS-CoV-2 Receptor Binding Domain Variants with Mutations N501Y or E484K in Human Milk from COVID-19-Vaccinated, -Recovered, and -Unvaccinated Women
  23. Capsule Independent Antimicrobial Activity Induced by Nanochitosan against Streptococcus pneumoniae
  24. A Murine Model for Enhancement of Streptococcus pneumoniae Pathogenicity upon Viral Infection and Advanced Age
  25. HAMLET a human milk protein‐lipid complex induces a pro‐inflammatory phenotype of myeloid cells
  26. The serine protease HtrA plays a key role in heat-induced dispersal of pneumococcal biofilms
  27. A Role of Epithelial Cells and Virulence Factors in Biofilm Formation by Streptococcus pyogenesIn Vitro
  28. Niche- and Gender-Dependent Immune Reactions in Relation to the Microbiota Profile in Pediatric Patients with Otitis Media with Effusion
  29. A Murine Model for Enhancement ofStreptococcus pneumoniaePathogenicity Upon Viral Infection and Advanced Age
  30. Chapter 7 – Pathogenesis of otitis media – A review of the literature between 2015 and 2019
  31. The human milk protein-lipid complex HAMLET disrupts glycolysis and induces death in Streptococcus pneumoniae
  32. HAMLET, a Protein Complex from Human Milk, Has Bactericidal Activity and Enhances the Activity of Antibiotics against Pathogenic Streptococci
  33. Growing and Characterizing Biofilms Formed by Streptococcus pneumoniae
  34. A Protein Complex from Human Milk Enhances the Activity of Antibiotics and Drugs againstMycobacterium tuberculosis
  35. BAMLET kills chemotherapy-resistant mesothelioma cells, holding oleic acid in an activated cytotoxic state
  36. Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection
  37. Streptococcus pneumoniae Modulates Staphylococcus aureus Biofilm Dispersion and the Transition from Colonization to Invasive Disease
  38. Streptococcus pneumoniae Otitis Media Pathogenesis and How It Informs Our Understanding of Vaccine Strategies
  39. Panel 6: Vaccines
  40. Panel 4: Report of the Microbiology Panel
  41. Low NF-κB Activation and Necroptosis in Alveolar Macrophages: A New Virulence Property of Streptococcus pneumoniae
  42. In Vitro and In Vivo Biofilm Formation by Pathogenic Streptococci
  43. Host Physiologic Changes Induced by Influenza A Virus Lead toStaphylococcus aureusBiofilm Dispersion and Transition from Asymptomatic Colonization to Invasive Disease
  44. In situ pneumococcal vaccine production and delivery through a hybrid biological-biomaterial vector
  45. Directed vaccination against pneumococcal disease
  46. Novel Strategy To Protect against Influenza Virus-Induced Pneumococcal Disease without Interfering with Commensal Colonization
  47. Structure and Potential Cellular Targets of HAMLET-like Anti-Cancer Compounds made from Milk Components
  48. Halothane Modulates the Type I Interferon Response to Influenza and Minimizes the Risk of Secondary Bacterial Pneumonia through Maintenance of Neutrophil Recruitment in an Animal Model
  49. Absence of capsule reveals glycan-mediated binding and recognition of salivary mucin MUC7 byStreptococcus pneumoniae
  50. Streptococcus pneumoniae biofilm formation and dispersion during colonization and disease
  51. Protective effects of human milk antimicrobial peptides against bacterial infection
  52. Mannosylated poly(beta-amino esters) for targeted antigen presenting cell immune modulation
  53. Pneumococcal Genetic Transformation During Colonization and Biofilm Formation
  54. Biomaterials at the interface of nano- and micro-scale vector–cellular interactions in genetic vaccine design
  55. Dynamic Changes in the Streptococcus pneumoniae Transcriptome during Transition from Biofilm Formation to Invasive Disease upon Influenza A Virus Infection
  56. Hybrid bio-synthetic gene delivery
  57. Monitoring Changes in Membrane Polarity, Membrane Integrity, and Intracellular Ion Concentrations in Streptococcus pneumoniae Using Fluorescent Dyes
  58. Pneumococcal Adaptive Responses to Changing Host Environments
  59. Small‐angle X‐ray scattering of BAMLET at pH 12: A complex of α‐lactalbumin and oleic acid
  60. Streptococcus pyogenes Biofilm Growth In Vitro and In Vivo and Its Role in Colonization, Virulence, and Genetic Exchange
  61. Biofilm Formation Enhances Fomite Survival of Streptococcus pneumoniae and Streptococcus pyogenes
  62. A Complex of Equine Lysozyme and Oleic Acid with Bactericidal Activity against Streptococcus pneumoniae
  63. Internalization and Trafficking of Nontypeable Haemophilus influenzae in Human Respiratory Epithelial Cells and Roles of IgA1 Proteases for Optimal Invasion and Persistence
  64. Interkingdom Signaling Induces Streptococcus pneumoniae Biofilm Dispersion and Transition from Asymptomatic Colonization to Disease
  65. Sensitization of Staphylococcus aureus to Methicillin and Other Antibiotics In Vitro and In Vivo in the Presence of HAMLET
  66. High Levels of Genetic Recombination during Nasopharyngeal Carriage and Biofilm Formation in Streptococcus pneumoniae
  67. The Human Milk Protein-Lipid Complex HAMLET Sensitizes Bacterial Pathogens to Traditional Antimicrobial Agents
  68. A Novel Initiation Mechanism of Death in Streptococcus pneumoniae Induced by the Human Milk Protein-Lipid Complex HAMLET and Activated during Physiological Death
  69. Pneumococcal Interactions with Epithelial Cells Are Crucial for Optimal Biofilm Formation and ColonizationIn VitroandIn Vivo
  70. Oleic acid is a key cytotoxic component of HAMLET-like complexes
  71. A novel method for preparation of HAMLET-like protein complexes
  72. Role of Dihydrolipoamide Dehydrogenase in Regulation of Raffinose Transport in Streptococcus pneumoniae
  73. Apoptosis-Like Death in Bacteria Induced by HAMLET, a Human Milk Lipid-Protein Complex
  74. Streptolysin O Inhibits Clathrin-Dependent Internalization of Group A Streptococcus
  75. PerR Confers Phagocytic Killing Resistance and Allows Pharyngeal Colonization by Group A Streptococcus
  76. Enzymatic Characterization of Dihydrolipoamide Dehydrogenase from Streptococcus pneumoniae Harboring Its Own Substrate
  77. Mg2+ signalling defines the group A streptococcal CsrRS (CovRS) regulon
  78. Capsule does not block antibody binding to PspA, a surface virulence protein of Streptococcus pneumoniae
  79. Enhancement of Streptolysin O Activity and Intrinsic Cytotoxic Effects of the Group A Streptococcal Toxin, NAD-Glycohydrolase
  80. Extracellular group A Streptococcus induces keratinocyte apoptosis by dysregulating calcium signalling
  81. Cytolysin-dependent evasion of lysosomal killing
  82. Relative Roles of Genetic Background and Variation in PspA in the Ability of Antibodies to PspA To Protect against Capsular Type 3 and 4 Strains of Streptococcus pneumoniae
  83. Regions of PspA/EF3296 Best Able To Elicit Protection against Streptococcus pneumoniae in a Murine Infection Model
  84. Characterization of the dihydrolipoamide dehydrogenase from Streptococcus pneumoniae and its role in pneumococcal infection
  85. Hamlet — A Complex from Human Milk that Induces Apoptosis in Tumor Cells but Spares Healthy Cells
  86. In Vivo Activation of Dendritic Cells and T Cells during Salmonella enterica Serovar Typhimurium Infection
  87. Characterization of Binding of Human Lactoferrin to Pneumococcal Surface Protein A
  88. Morphological and functionalin vitroandin vivocharacterization of the mouse corpus cavernosum
  89. A folding variant of human α‐lactalbumin induces mitochondrial permeability transition in isolated mitochondria
  90. Conversion of α-lactalbumin to a protein inducing apoptosis
  91. A folding variant of α‐lactalbumin with bactericidal activity against Streptococcus pneumoniae
  92. A folding variant of α‐lactalbumin with bactericidal activity against Streptococcus pneumoniae
  93. Protease Activation in Apoptosis Induced by MAL
  94. Molecular Characterization of  -Lactalbumin Folding Variants That Induce Apoptosis in Tumor Cells
  95. Multimeric α-Lactalbumin from Human Milk Induces Apoptosis through a Direct Effect on Cell Nuclei
  96. Aspects on the Interaction ofStreptococcus pneumoniaeandHaemophilus influenzaewith Human Respiratory Tract Mucosa
  97. Antibodies to pneumococcal polysaccharides in human milk: lack of relationship to colonization and acute otitis media
  98. Apoptosis induced by a human milk protein.